Twist Bioscience Corp TWST
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026
-
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
-
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
-
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
-
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
Trading Information
- Previous Close Price
- $93.85
- Day Range
- $87.32–96.76
- 52-Week Range
- $23.30–105.47
- Bid/Ask
- $86.50 / $96.00
- Shares Outstanding
- 62.27M
- Market Cap
- $5.45B
- Volume/Avg
- 931,086 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 13.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- < 0.01%
Company Profile
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 979
- Website
- https://www.twistbioscience.com
Valuation
|
Metric
|
TWST
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 11.94 |
Price/Sales | 12.98 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TWST
|
|---|---|
Quick Ratio | 2.16 |
Current Ratio | 2.70 |
Interest Coverage | — |
Quick Ratio
TWST
Profitability
|
Metric
|
TWST
|
|---|---|
Return on Assets (Normalized) | −9.91% |
Return on Equity (Normalized) | −13.75% |
Return on Invested Capital (Normalized) | −12.93% |
Return on Assets
TWST
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|pNdPm^@ | LOCK|^qr | $198B | |||
| Danaher Corp
DHR
| LOCK|fd?tt#x | LOCK|^Bj | $144B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|js@%!cvB | LOCK|!VZ | $45B | |||
| Agilent Technologies Inc
A
| LOCK|jJTY<H!< | LOCK|QBp | $37B | |||
| Waters Corp
WAT
| LOCK|@mjWNMs | LOCK|QT> | $36B | |||
| IQVIA Holdings Inc
IQV
| LOCK|>Kk@%b | LOCK|WD<%? | $34B | |||
| Illumina Inc
ILMN
| LOCK|d?ttTKm | LOCK|kb>> | $28B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|>N!cxMRL | LOCK|!B#Z | $26B | |||
| Quest Diagnostics Inc
DGX
| LOCK|!!Kx%? | LOCK|?QGY | $23B | |||
| Labcorp Holdings Inc
LH
| LOCK|w>l?H%Y@ | LOCK|^>kFt | $23B |
United States